70 189

Multi-institutional analysis of T3 subtypes and adjuvant radiotherapy effects in resected T3N0 non-small cell lung cancer patients

Authors
 Yunseon Choi  ;  Ik Jae Lee  ;  Chang Young Lee  ;  Jae Ho Cho  ;  Won Hoon Choi  ;  Hong In Yoon  ;  Yun-Han Lee  ;  Chang Geol Lee  ;  Ki Chang Keum  ;  Kyung Young Chung  ;  Seok Jin Haam  ;  Hyo Chae Paik  ;  Kang Kyoo Lee  ;  Sun Rock Moon  ;  Jong-Young Lee  ;  Kyung-Ran Park  ;  Young Suk Kim 
Citation
 Radiation Oncology Journal, Vol.33(2) : 75-82, 2015 
Journal Title
 Radiation Oncology Journal 
ISSN
 2234-1900 
Issue Date
2015
Abstract
PURPOSE: We evaluated the prognostic significance of T3 subtypes and the role of adjuvant radiotherapy in patients with resected the American Joint Committee on Cancer stage IIB T3N0M0 non-small cell lung cancer (NSCLC). MATERIALS AND METHODS: T3N0 NSCLC patients who underwent resection from January 1990 to October 2009 (n = 102) were enrolled and categorized into 6 subgroups according to the extent of invasion: parietal pleura chest wall invasion, mediastinal pleural invasion, diaphragm invasion, separated tumor nodules in the same lobe, endobronchial tumor <2 cm distal to the carina, and tumor-associated collapse. RESULTS: The median overall survival (OS) and disease-free survival (DFS) were 55.3 months and 51.2 months, respectively. In postoperative T3N0M0 patients, the tumor size was a significant prognostic factor for survival (OS, p = 0.035 and DFS, p = 0.035, respectively). Patients with endobronchial tumors within 2 cm of the carina also showed better OS and DFS than those in the other T3 subtypes (p = 0.018 and p = 0.016, respectively). However, adjuvant radiotherapy did not cause any improvement in survival (OS, p = 0.518 and DFS, p = 0.463, respectively). Only patients with mediastinal pleural invasion (n = 25) demonstrated improved OS and DFS after adjuvant radiotherapy (n = 18) (p = 0.012 and p = 0.040, respectively). CONCLUSION: The T3N0 NSCLC subtype that showed the most favorable prognosis is the one with endobronchial tumors within 2 cm of the carina. Adjuvant radiotherapy is not effective in improving survival outcome in resected T3N0 NSCLC.
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/140668
Files in This Item:
T201502680.pdf Download
DOI
10.3857/roj.2015.33.2.75
Appears in Collections:
1. Journal Papers (연구논문) > 1. College of Medicine (의과대학) > Dept. of Pharmacology (약리학교실)
1. Journal Papers (연구논문) > 1. College of Medicine (의과대학) > Dept. of Radiation Oncology (방사선종양학교실)
1. Journal Papers (연구논문) > 1. College of Medicine (의과대학) > Dept. of Thoracic and Cardiovascular Surgery (흉부외과학교실)
Yonsei Authors
금기창(Keum, Ki Chang)
백효채(Paik, Hyo Chae) ORCID logo https://orcid.org/0000-0001-9309-8235
윤홍인(Yoon, Hong In) ORCID logo https://orcid.org/0000-0002-2106-6856
이윤한(Lee, Yun Han)
이익재(Lee, Ik Jae) ORCID logo https://orcid.org/0000-0001-7165-3373
이창걸(Lee, Chang Geol) ORCID logo https://orcid.org/0000-0002-8702-881X
이창영(Lee, Chang Young)
정경영(Chung, Kyung Young)
조재호(Cho, Jae Ho) ORCID logo https://orcid.org/0000-0001-9966-5157
최원훈(Choi, Won Hoon)
함석진(Haam, Seok Jin)
Export
RIS (EndNote)
XLS (Excel)
XML
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse